Lisa Modelevsky

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort”.

Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort

Annals of Lymphoma(2023)10.21037/aol-22-19

N/A

0DataRank · unranked

6 citations

Samantha Reiss, Lisa Modelevsky, Lauren Schaff, Anne S. Reiner, Katherine S. Panageas +2 more

Treatment of methotrexate-refractory primary central nervous system lymphoma (PCNSL) at Memorial Sloan Kettering Cancer Center

Leukemia & lymphoma/Leukemia and lymphoma(2024)10.1080/10428194.2024.2343778

N/A

0DataRank · unranked

1 citations

Lisa Modelevsky, Anne S. Reiner, Christian Grommes, S. Cherian